[HTML][HTML] Ph 染色体样急性淋巴细胞白血病的研究进展
吴玉玲， 向兵， 刘霆 - Chinese Journal of Hematology, 2019 - ncbi.nlm.nih.gov
急性淋巴细胞白血病(ALL) 是前体淋巴细胞发生克隆性异常增殖所致的恶性疾病, 近年来,
随着分子生物学基因组测序技术的进步, 在儿童和成人ALL 患者中发现了一个高危的B-ALL …
随着分子生物学基因组测序技术的进步, 在儿童和成人ALL 患者中发现了一个高危的B-ALL …
Research progress in Ph-like acute lymphoblastic leukemia
YL Wu, B Xiang, T Liu - Zhonghua xue ye xue za zhi= Zhonghua …, 2019 - europepmc.org
急性淋巴细胞白血病 (ALL) 是前体淋巴细胞发生克隆性异常增殖所致的恶性疾病, 近年来,
随着分子生物学基因组测序技术的进步, 在儿童和成人 ALL 患者中发现了一个高危的 B-ALL …
随着分子生物学基因组测序技术的进步, 在儿童和成人 ALL 患者中发现了一个高危的 B-ALL …
Identification of new therapeutic targets in CRLF2-overexpressing B-ALL through discovery of TF-gene regulatory interactions
Although genetic alterations are initial drivers of disease, aberrantly activated transcriptional
regulatory programs are often responsible for the maintenance and progression of cancer …
regulatory programs are often responsible for the maintenance and progression of cancer …
[HTML][HTML] Signaling input from divergent pathways subverts malignant B-cell transformation
Background and significance: Normal B-cells constantly exchange information with their
environment and depend on external cues for proliferation and survival that engage multiple …
environment and depend on external cues for proliferation and survival that engage multiple …
Opredelitev delecij gena IKZF1 pri otrocih z B-celično akutno limfoblastno levkemijo
G Marinšek - 2019 - repozitorij.uni-lj.si
Akutna limfoblastna levkemija (ALL), za katero je značilna maligna transformacija predniških
celic B ali T limfocitov, je najpogostejša rakava bolezen pri otrocih. Sodobni načini …
celic B ali T limfocitov, je najpogostejša rakava bolezen pri otrocih. Sodobni načini …
[PDF][PDF] A B-cell acute lymphoblastic leukemia regulatory network defines novel therapeutic targets in IGH-CRLF2 patients
A B-cell acute lymphoblastic leukemia regulatory network defines novel therapeutic targets in
IGH-CRLF2 patients Page 1 1 A B-cell acute lymphoblastic leukemia regulatory network defines …
IGH-CRLF2 patients Page 1 1 A B-cell acute lymphoblastic leukemia regulatory network defines …
[PDF][PDF] 5. Newer approaches towards theranostics in Acute Lymphoblastic Leukemia
GU Raval - Guidelines for the Management for Clinical Genomics …, 2019 - tmc.gov.in
Hematopoietic stem cells are an important source of different lymphocytes which essentially
forms the basis of our immune system. The lymphoid malignancies include tumors of cells …
forms the basis of our immune system. The lymphoid malignancies include tumors of cells …
Interrogating the Mechanistic Basis for Cytokine-Mediated Glucocorticoid Resistance in Lymphoid-Driven Diseases
LK Meyer - 2019 - escholarship.org
Glucocorticoids (GCs) are potently immunosuppressive due to their pro-apoptotic effects on
lymphoid cells, leading to their utility in a wide range of clinical contexts including …
lymphoid cells, leading to their utility in a wide range of clinical contexts including …
[PDF][PDF] Methotrexat-assoziierte Toxizität bei Kindern mit akuter lymphoblastischer Leukämie und Down Syndrom
M Kroll - 2019 - macau.uni-kiel.de
Kinder mit Down Syndrom (DS) haben ein erhöhtes Risiko an einer akuten
lymphoblastischen Leukämie (ALL) zu erkranken (DS-ALL) und stellen einen Anteil von bis …
lymphoblastischen Leukämie (ALL) zu erkranken (DS-ALL) und stellen einen Anteil von bis …